American College of Cardiology

OCTOBER 30, 2024

Several abstracts presented at TCT 2024, taking place Oct.

Chest Pain 52

Chest Pain Coronary Artery Disease TAVR Bicuspid/Mitral 52

American College of Cardiology

MARCH 31, 2025

Refocusing and reframing the definition and discussion of coronary artery disease (CAD) from late-stage ischemia and acute coronary events to early detection of coronary artery atheroma and prevention of advanced acute coronary syndrome (ACS) has the potential to save 8.7

Coronary Artery Disease 44

Coronary Artery Disease Ischemia Article 44

Open Heart

JULY 24, 2023

Introduction Current guideline recommend functional imaging for myocardial ischaemia if coronary CT angiography (CTA) has shown coronary artery disease (CAD) of uncertain functional significance. However, diagnostic accuracy of selective myocardial perfusion imaging after coronary CTA is currently unclear.

Coronary Artery Disease 52

Coronary Artery Disease Angina Article Research 52

American College of Cardiology

MARCH 5, 2024

Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs. In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M.

Coronary Artery Disease 50

Coronary Artery Disease Outcomes Article 50

The British Journal of Cardiology

APRIL 2, 2025

HBOT is a promising treatment modality for coronary artery disease (CAD), where outcomes are frequently poor despite early revascularisation. Hyperbaric oxygen therapy (HBOT) is successfully implemented for the treatment of several disorders.

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Article 40

Cardiology Update

JANUARY 28, 2024

The optimal management of concomitant chronic obstructive coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. While some advocate for pre-TAVR percutaneous coronary intervention, others adopt an expectant approach. Original article: Persits I et al.

TAVR 115

TAVR Aortic valve Outcomes Coronary Artery Disease 115

Cardiology Update

MARCH 19, 2024

Original article: Kim et al. The post Target Lesion Revascularization Not Linked to Increased Mortality After PCI with DES for Left Main Coronary Artery Disease appeared first on Cardiology Update. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram.

Coronary Artery Disease 52

Coronary Artery Disease Coronary Artery Bypass Graft Research Article 52

Nature Reviews - Cardiology

MAY 6, 2024

In this Perspective article, the authors propose that a similar illusion of revascularization exists for contemporary percutaneous revascularization in patients with coronary artery disease and ischaemia, and identify how outcomes might be improved.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Article Outcomes 64

The British Journal of Cardiology

MARCH 7, 2024

The National Institute for Health and Care Excellence (NICE) advise against routine testing for coronary artery disease (CAD) in patients with non-anginal chest pain (NACP). Over 23 months, 866 patients with NACP underwent CTCA.

Coronary Artery Disease 40

Coronary Artery Disease Chest Pain Risk Factors Hypertension 40

Circulation

JUNE 30, 2024

Circulation, Volume 150, Issue 1 , Page e3-e4, July 2, 2024.

Coronary Artery Disease 49

Coronary Artery Disease Angina Article Circulation 49

Journal of Cardiovascular Pharmacology

FEBRUARY 10, 2025

The management of antiplatelet therapy in coronary artery disease (CAD) is one of the most debated topics in cardiology. The management of antiplatelet therapy in coronary artery disease (CAD) is one of the most debated topics in cardiology.

Coronary Artery Disease 40

Coronary Artery Disease Research Article 40

Cardiovascular Diabetology

AUGUST 27, 2024

Based on a predefined PROSPERO protocol, studies published as full-length, English-language journal articles that reported the presence of GDM during pregnancy and its association with any CVD development post-delivery were selected. All studies were evaluated using the Newcastle-Ottawa Scale.

Cardiovascular Disease 85

Cardiovascular Disease Diabetes Coronary Artery Disease Cerebrovascular Disease 85

American College of Cardiology

FEBRUARY 5, 2024

Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.

Hypertension 75

Hypertension Coronary Artery Disease Kidney Disease Dementia 75

American College of Cardiology

APRIL 26, 2024

Since limb events are major drivers of morbidity in diabetic patients with peripheral (PAD) and coronary artery disease (CAD), does the addition of ticagrelor to background therapy of aspirin improve limb events?

Diabetes 65

Diabetes Coronary Artery Disease Outcomes Article 65

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. Women continue to enjoy a greater life expectancy than men.

Heart Failure 59

Heart Failure Cancer Coronary Artery Disease Article 59

American College of Cardiology

JANUARY 3, 2024

The goal of the REVIVED-BCIS2 trial was to evaluate percutaneous coronary intervention (PCI) plus optimal medical therapy compared with optimal medical therapy alone among individuals with left ventricular ejection fraction (LVEF) ≤35% and extensive coronary artery disease (CAD).

Coronary Artery Disease 71

Coronary Artery Disease Article 71

American College of Cardiology

JANUARY 23, 2024

Both the COMPLETE and PRAMI trial findings supported the benefits of complete revascularization over culprit-only percutaneous coronary intervention (PCI) in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease.

Myocardial Infarction 67

Myocardial Infarction Coronary Artery Disease Article 67

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 892-893, March 12, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Article Circulation 45

American College of Cardiology

FEBRUARY 1, 2025

Self-reported adherence to cardiovascular medications in patients who have coronary artery disease is for the combination of aspirin, beta-blocker and a lipid-lowering agent in surveys.7 Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. J Am Geriatr Soc.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Dr. Paddy Barrett

APRIL 4, 2025

Remember, after reading all my newsletter articles, you will have an excellent idea of how to do this. This is all about understanding whether a 'risk factor,’ e.g. High LDL-C cholesterol, has translated into significant ‘disease,’ e.g. coronary artery disease.

Blood Pressure 97

Blood Pressure Exercise Heart Disease Cholesterol 97

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 896-896, March 12, 2024.

Coronary Artery Disease 45

Coronary Artery Disease Article Circulation 45

American College of Cardiology

JULY 10, 2024

What is the outcome of contemporary revascularization strategies in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease (CAD)?

Coronary Artery Disease 55

Coronary Artery Disease Myocardial Infarction Outcomes Article 55

American College of Cardiology

APRIL 16, 2025

Individuals with a high genetic risk for coronary artery disease (CAD) also have an increased risk of developing dementia, according to a large UK population study published April 4 in Circulation.

Dementia 48

Dementia Coronary Artery Disease Circulation Article 48

European Journal of Heart Failure

MARCH 10, 2025

Participants ( n =57755) with CH had significantly greater risk of new-onset HF compared to the non-CH group (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.121.35, p <0.0001; I 2 =0%), irrespective of a prior history of coronary artery disease.

Heart Failure 40

Heart Failure Outcomes Coronary Artery Disease Risk Factors 40

American College of Cardiology

MARCH 5, 2024

A 59-year-old woman with newly diagnosed nonobstructive coronary artery disease (CAD) presents to the sports cardiology clinic. She is a long-distance runner who has participated in numerous marathons over the previous 20 years.

Coronary Artery Disease 62

Coronary Artery Disease Article 62

American College of Cardiology

SEPTEMBER 1, 2024

The goal of the EPIC-CAD trial was to evaluate edoxaban monotherapy compared with edoxaban/antiplatelet therapy among patients with atrial fibrillation (AF) and chronic coronary disease.

Atrial Fibrillation 44

Atrial Fibrillation Coronary Artery Disease Article 44

American College of Cardiology

MARCH 26, 2024

What are clinical outcomes among patients presenting with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) and multivessel coronary artery disease (MVD) and undergoing immediate complete revascularization (ICR) compared to staged complete revascularization (SCR)?

Coronary Artery Disease 61

Coronary Artery Disease Outcomes Article 61

American College of Cardiology

MARCH 29, 2025

The goal of the WARRIOR trial was to determine whether intensive medical therapy vs. usual care would reduce first occurrence of major adverse cardiovascular events (MACE) in women with ischemia and nonobstructive coronary artery disease (INOCA) at 5-year follow-up.

Ischemia 48

Ischemia Coronary Artery Disease Article 48

Circulation

MARCH 10, 2024

Circulation, Volume 149, Issue 11 , Page 894-895, March 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Article Circulation 40

American College of Cardiology

MAY 24, 2024

The goal of the FIRE trial was to evaluate multivessel revascularization guided by coronary physiology compared with culprit-only revascularization among elderly patients with acute myocardial infarction (MI) and multivessel coronary artery disease (CAD).

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Physiology Article 52

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 52

Aortic valve Coronary Artery Disease TAVR Aortic 52

American College of Cardiology

JUNE 20, 2024

Does coronary arterial inflammation drive cardiac mortality or major adverse cardiac events (MACE) in patients with or without coronary artery disease (CAD), and can an artificial intelligence (AI)-Risk prognostic algorithm be used as an alternative to traditional risk factor-based calculators to enhance clinical management?

Coronary Artery Disease 53

Coronary Artery Disease Risk Factors Article 53

American College of Cardiology

DECEMBER 19, 2024

The goal of the TCW trial was to test the noninferiority and, if positive, superiority, of percutaneous coronary intervention (PCI) with transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) and coronary artery bypass grafting (CABG) in severe aortic stenosis (AS) with comorbid coronary artery disease (..)

Coronary Artery Bypass Graft 53

Coronary Artery Bypass Graft Aortic valve Coronary Artery Disease Aortic 53

American College of Cardiology

MARCH 5, 2025

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major adverse cardiac events (MACE).

Angioplasty 50

Angioplasty Coronary Artery Disease Article 50

American College of Cardiology

AUGUST 31, 2024

The goal of the NOTION-3 trial was to evaluate percutaneous coronary intervention (PCI) compared with conservative therapy among patients with obstructive coronary artery disease undergoing transcatheter aortic valve implantation (TAVI).

Aortic valve 48

Aortic valve Aortic Coronary Artery Disease Article 48

American College of Cardiology

NOVEMBER 20, 2024

Which genetic and cardiovascular risk factors are aortic stenosis (AS)-specific, and which could be shared between AS and with coronary artery disease (CAD)?

Stenosis 46

Stenosis Aortic Coronary Artery Disease Risk Factors 46

American College of Cardiology

JUNE 26, 2024

Coronary computed tomography (CCTA), used for first-line investigation of chest pain, has revealed there is a large group of individuals without obstructive coronary artery disease (CAD) for whom there is an unclear prognosis and management.

Chest Pain 52

Chest Pain Coronary Artery Disease Article 52